Bleeding in Patients Undergoing CABG (Coronary Artery Bypass Graft) During Dual Antiplatelet Therapy
Terminated
- Conditions
- Acute Coronary Syndrome
- Registration Number
- NCT02030548
- Lead Sponsor
- Medical University of Graz
- Brief Summary
The aim of the study is to evaluate surgery-related bleeding and mortality in patients needing acute coronary artery bypass grafting with or without valve replacement during dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker (Clopidogrel, Prasugrel, Ticagrelor)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 144
Inclusion Criteria
consecutive patients undergoing acute CABG with or without valve replacement within 7 days after last intake of dual antiplatelet therapy
Exclusion Criteria
concomitant oral anticoagulants dialysis surgery employing hypothermic cardiac arrest
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method calculated blood loss until postoperative day 5
- Secondary Outcome Measures
Name Time Method mortality from index surgery until one year after index surgery
Trial Locations
- Locations (1)
Dept. of Anesthesiology and Intensive Care Medicine
🇦🇹Graz, Styria, Austria